Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Therapeutic Drug Monitoring
54%
Multi-Drug-Resistant Tuberculosis
37%
Neoplasm
35%
Voriconazole
24%
Tablet
24%
Inflammatory Bowel Disease
24%
Biodistribution
23%
Adverse Event
22%
Zirconium 89
20%
Linezolid
17%
Adverse Drug Reaction
17%
Normal Human
16%
Fluconazole
16%
Bioavailability
16%
Medication Error
15%
Trastuzumab
14%
Infliximab
14%
Clinical Trial
14%
Radiopharmaceutical Agent
14%
Antiinfective Agent
13%
Gamma Urogastrone
13%
Indium 111
13%
Monoclonal Antibody
12%
Extensively Drug-Resistant Tuberculosis
12%
Mycobacterium Tuberculosis
11%
Inflammation
11%
Levofloxacin
11%
Malignant Neoplasm
11%
Dosage Forms
10%
Pharmacodynamics
10%
Mouse
10%
Bevacizumab
10%
Pharmacokinetic Modeling
10%
Everolimus
9%
Vasculotropin A
9%
Tuberculostatic Agent
9%
Moxifloxacin
9%
Ertapenem
9%
Metastatic Breast Cancer
8%
Ethambutol
8%
Clozapine
8%
Anidulafungin
8%
Budesonide
8%
Acetylsalicylic Acid
8%
Kanamycin
8%
Amikacin
8%
Hospital Pharmacy
8%
Antifungal Agent
8%
Prospective Study
8%
Keyphrases
Therapeutic Drug Monitoring
28%
Pharmacokinetics
18%
Tuberculosis
17%
Restricted Sampling
17%
Population Pharmacokinetic Model
16%
Multidrug-resistant Tuberculosis (MDR-TB)
13%
Inflammatory Bowel Disease
12%
Critically Ill Patients
12%
Infliximab
11%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
9%
Voriconazole
8%
ColoPulse
8%
Tuberculosis Drugs
8%
Area under the Concentration-time Curve
8%
Tuberculosis Patients
7%
First-line Anti-tuberculosis Drugs
7%
TB Patients
7%
Adverse Events
7%
Population Pharmacokinetics
6%
Human Plasma
6%
Dutch
6%
Clinical Practice
6%
Hospitalized Patients
6%
Aminoglycosides
6%
Pharmacokinetic Modeling
5%
Amikacin
5%
Kanamycin
5%
Anidulafungin
5%
Optimal Sample Size
5%
Target Attainment
5%
Antimicrobial
5%
Penicillin
5%
Pyrazinamide
5%
Invasive Candidiasis
5%
Trough Concentration
5%
AIDS/HIV
5%
Medicine and Dentistry
Neoplasm
30%
Positron Emission Tomography
20%
Zirconium 89
20%
Biodistribution
15%
Trastuzumab
12%
Tumor Xenograft
12%
Radioactive Tracer
12%
Metastatic Breast Cancer
11%
Gamma Urogastrone
11%
Monoclonal Antibody
10%
Epidermal Growth Factor Receptor 2
8%
Vasculotropin A
8%
Hospital Pharmacy
8%
Inflammatory Bowel Disease
8%
Positron Emission Tomography
8%
Bevacizumab
8%
Biological Marker
8%
Bioburden
7%
Ovarian Cancer
6%
Everolimus
5%
Outpatient
5%
Pancreas Tumor
5%
Infliximab
5%
Mesothelin
5%
Disease
5%
Indium 111
5%
